Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study.

Seicean S, Seicean A, Plana JC, Budd GT, Marwick TH.

J Am Coll Cardiol. 2012 Dec 11;60(23):2384-90. doi: 10.1016/j.jacc.2012.07.067. Epub 2012 Nov 7.

PMID:
23141499
[PubMed - indexed for MEDLINE]
Free Article
2.

Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis.

Kalam K, Marwick TH.

Eur J Cancer. 2013 Sep;49(13):2900-9. doi: 10.1016/j.ejca.2013.04.030. Epub 2013 May 22. Review.

PMID:
23706982
[PubMed - indexed for MEDLINE]
3.

Statin use in heart failure: a cause for concern?

Raina A, Pickering T, Shimbo D.

Am Heart J. 2006 Jul;152(1):39-49. Review.

PMID:
16824830
[PubMed - indexed for MEDLINE]
4.

Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.

Jensen BV.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S15-21. Review.

PMID:
16781285
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk